402 filings
8-K/A
COR
Cencora Inc.
15 Mar 24
Departure of Directors or Certain Officers
4:35pm
8-K
COR
Cencora Inc.
15 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:33pm
8-K
COR
Cencora Inc.
12 Mar 24
Cencora Announces Leadership Succession Plan
8:46am
8-K
COR
Cencora Inc.
27 Feb 24
1.05
5:15pm
8-K
COR
Cencora Inc.
9 Feb 24
Entry into a Material Definitive Agreement
4:05pm
8-K
l990 fbjc
7 Feb 24
Cencora Closes $500 Million Senior Notes Offering
1:48pm
8-K
llmukq4gq mjj
7 Feb 24
Cencora Prices $500 Million 5.125% Senior Notes Due 2034
12:00am
8-K
24ztywpgkszujce3
31 Jan 24
Cencora Reports Fiscal 2024 First Quarter Results
6:37am
8-K
wtsh22skr lt8ym05l5
16 Jan 24
Departure of Directors or Certain Officers
4:44pm
8-K
23kzqo938hf9 k32ymt8
26 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
2nw0vowx
21 Dec 23
Other Events
5:08pm
8-K
lfcs 6y7e7mj54yqzj5
14 Nov 23
Entry into a Material Definitive Agreement
12:00am
8-K
5ts33g
2 Nov 23
Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
6:35am
8-K
jjjy8osz53n 8e5kl5o2
10 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
x3e0ny0zwqmbx bxq
30 Aug 23
AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care
8:30am
8-K
ryp2i8
15 Aug 23
Amerisourcebergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors
8:14am
8-K
hxyrq
8 Aug 23
Entry into a Material Definitive Agreement
5:12pm
8-K
uk1b37tj3e36e5e60
2 Aug 23
Fiscal 2023 Third Quarter Results
6:34am
8-K
fqxpoo4zi gxhu
20 Jun 23
Entry into a Material Definitive Agreement
7:03am
8-K
bzr4jonljh
9 Jun 23
TPG and AmerisourceBergen Announce Completion of Acquisition of ONEONCOLOGY
5:03pm